Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

India Montelukast API Market

ID: MRFR/HC/51336-HCR
200 Pages
Rahul Gotadki
Last Updated: February 06, 2026

India Montelukast API Market Research Report By Application (Asthma, Allergic Rhinitis, Bronchospasm, Urticaria, Others) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

India Montelukast API Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Industrial Automation & Equipment, BY Application (USD Million)
  49.     4.1.1 Asthma
  50.     4.1.2 Allergic Rhinitis
  51.     4.1.3 Bronchospasm
  52.     4.1.4 Urticaria
  53.     4.1.5 Others
  54. 5 SECTION V: COMPETITIVE ANALYSIS
  55.   5.1 Competitive Landscape
  56.     5.1.1 Overview
  57.     5.1.2 Competitive Analysis
  58.     5.1.3 Market share Analysis
  59.     5.1.4 Major Growth Strategy in the Industrial Automation & Equipment
  60.     5.1.5 Competitive Benchmarking
  61.     5.1.6 Leading Players in Terms of Number of Developments in the Industrial Automation & Equipment
  62.     5.1.7 Key developments and growth strategies
  63.       5.1.7.1 New Product Launch/Service Deployment
  64.       5.1.7.2 Merger & Acquisitions
  65.       5.1.7.3 Joint Ventures
  66.     5.1.8 Major Players Financial Matrix
  67.       5.1.8.1 Sales and Operating Income
  68.       5.1.8.2 Major Players R&D Expenditure. 2023
  69.   5.2 Company Profiles
  70.     5.2.1 Merck & Co (US)
  71.       5.2.1.1 Financial Overview
  72.       5.2.1.2 Products Offered
  73.       5.2.1.3 Key Developments
  74.       5.2.1.4 SWOT Analysis
  75.       5.2.1.5 Key Strategies
  76.     5.2.2 Mylan N.V. (US)
  77.       5.2.2.1 Financial Overview
  78.       5.2.2.2 Products Offered
  79.       5.2.2.3 Key Developments
  80.       5.2.2.4 SWOT Analysis
  81.       5.2.2.5 Key Strategies
  82.     5.2.3 Teva Pharmaceutical Industries Ltd (IL)
  83.       5.2.3.1 Financial Overview
  84.       5.2.3.2 Products Offered
  85.       5.2.3.3 Key Developments
  86.       5.2.3.4 SWOT Analysis
  87.       5.2.3.5 Key Strategies
  88.     5.2.4 Cipla Ltd (IN)
  89.       5.2.4.1 Financial Overview
  90.       5.2.4.2 Products Offered
  91.       5.2.4.3 Key Developments
  92.       5.2.4.4 SWOT Analysis
  93.       5.2.4.5 Key Strategies
  94.     5.2.5 Aurobindo Pharma Ltd (IN)
  95.       5.2.5.1 Financial Overview
  96.       5.2.5.2 Products Offered
  97.       5.2.5.3 Key Developments
  98.       5.2.5.4 SWOT Analysis
  99.       5.2.5.5 Key Strategies
  100.     5.2.6 Hikma Pharmaceuticals PLC (GB)
  101.       5.2.6.1 Financial Overview
  102.       5.2.6.2 Products Offered
  103.       5.2.6.3 Key Developments
  104.       5.2.6.4 SWOT Analysis
  105.       5.2.6.5 Key Strategies
  106.     5.2.7 Zydus Cadila (IN)
  107.       5.2.7.1 Financial Overview
  108.       5.2.7.2 Products Offered
  109.       5.2.7.3 Key Developments
  110.       5.2.7.4 SWOT Analysis
  111.       5.2.7.5 Key Strategies
  112.     5.2.8 Sun Pharmaceutical Industries Ltd (IN)
  113.       5.2.8.1 Financial Overview
  114.       5.2.8.2 Products Offered
  115.       5.2.8.3 Key Developments
  116.       5.2.8.4 SWOT Analysis
  117.       5.2.8.5 Key Strategies
  118.   5.3 Appendix
  119.     5.3.1 References
  120.     5.3.2 Related Reports
  121. 6 LIST OF FIGURES
  122.   6.1 MARKET SYNOPSIS
  123.   6.2 INDIA MARKET ANALYSIS BY APPLICATION
  124.   6.3 KEY BUYING CRITERIA OF INDUSTRIAL AUTOMATION & EQUIPMENT
  125.   6.4 RESEARCH PROCESS OF MRFR
  126.   6.5 DRO ANALYSIS OF INDUSTRIAL AUTOMATION & EQUIPMENT
  127.   6.6 DRIVERS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
  128.   6.7 RESTRAINTS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
  129.   6.8 SUPPLY / VALUE CHAIN: INDUSTRIAL AUTOMATION & EQUIPMENT
  130.   6.9 INDUSTRIAL AUTOMATION & EQUIPMENT, BY APPLICATION, 2024 (% SHARE)
  131.   6.10 INDUSTRIAL AUTOMATION & EQUIPMENT, BY APPLICATION, 2024 TO 2035 (USD Million)
  132.   6.11 BENCHMARKING OF MAJOR COMPETITORS
  133. 7 LIST OF TABLES
  134.   7.1 LIST OF ASSUMPTIONS
  135.     7.1.1
  136.   7.2 India MARKET SIZE ESTIMATES; FORECAST
  137.     7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  138.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  139.     7.3.1
  140.   7.4 ACQUISITION/PARTNERSHIP
  141.     7.4.1

India Industrial Automation & Equipment Market Segmentation

Industrial Automation & Equipment By Application (USD Million, 2025-2035)

  • Asthma
  • Allergic Rhinitis
  • Bronchospasm
  • Urticaria
  • Others

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions